Tagged with AI

AIFD - Association of Research-Based Pharmaceutical Companies Pharmaceutical Executive and Focus Reports are of course about the industry but also about the people making it happen. So before anything would you like to introduce yourself to our readers and expose the career path that has led you to take the helm of Turkey’s leader in the pharmaceutical…

AIFD - Association of Research-Based Pharmaceutical Companies In an environment where the line between generic and innovator companies is less and less relevant, due to the growing trend of innovators integrating generics products in their portfolio through acquisitions, to what extent has the role of association evolved? Despite the growing trend of integrating innovative products with generics,…

DAIICHI SANKYO TURKEY Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how it positions itself in this market? Daiichi Sankyo entered the Turkish market four years ago. At the time, little did we know that we…

BIOTEC Thailand As one of the figureheads of the BIOTECh industry in Thailand, could you introduce your background to our readers? I was trained as a biochemist in Thailand, and did my Master’s Degree and PhD in the US at the University of Connecticut. I did two post-Doctorates, one at Rutgers University…

Roche Ukraine As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company? The last two years have been very important and active for the development of Roche in Ukraine, particularly since we…

Nobel Pharma Ukraine Nobel Pharma has quite a history in the CIS region as this region is becoming increasingly important for the company. What is the company’s story in Ukraine? Nobel Pharma Ukraine has been established 6 years ago, we have finished 5 years of active marketing in Ukraine. First let me provide…

Teva Ukraine Since 2006 Teva has been on a solid phase of growth and consolidation, mainly through the acquisitions of IVAX in 2006, Pliva (Barr) in 2008 and ratiopharm in 2010, which have transformed the company from the number 40 global pharmaceutical player to a top-10 pharma company today. As the person…

Nycomed Ukraine Following Takeda’s acquisition of Nycomed earlier this year, how has the transaction affected your operations in Ukraine and what synergies were generated by it? Regarding the integration process, we are adapting our corporate cultures as quickly as possible. Luckily, I found out that both our cultures are very similar. It…

Aipm ukraine What was the market need that spawned the creation of AIPM in 2009 considering that there were already other trade associations in Ukraine that were representing the interests of international pharmaceutical companies? What was the vision for this association? The idea of establishing AIPM originated much before 2009 and it…

Hospira Taiwan What is exciting about the Taiwanese market for Hospira today? Hospira is a US-based company, which used to be part of Abbott Laboratories. A major part of the portfolio for the company is devices, which is mainly driven by its Medication Management Systems (MMS) portfolio. The rest of the company’s…

Eisai Europe As the head of Eisai’s European operations, how would you assess the relevance of the European market for Eisai’s global operations when compared to the US or emerging markets? Gary Hendler (GH): Eisai are currently present in 17 European markets as Eisai and several others via distributors. However it is…

Array As a Taiwanese national and Country Head of Novartis Taiwan, what is your opinion on the current state of the pharmaceutical industry in Taiwan, and what are your hopes for the future? I am of the opinion that it is going to get worse before it gets better. The National…